Company Profile
Fujian Yangzhenhua 851 Biological Technology Co., Ltd. was registered and founded in Fuzhou Economic and Technology Development Zone in 1990. The Company has modernized office buildings in downtown Fuzhou, sets up 20-mu garden-style factory in accordance with GMP standard in Fuzhou Economic and Technological Development Zone, and owns a 1600-mu experimentation base in the state of Kansas, US. The Factory in the Development District was built and put into commissioning in 1993, has production lines to produce drugs, health food and foodstuffs, and has acquired approval certificates and production license related with medication, health care food and foodstuffs. The Company has passed GMP certification, ISO9001 certification and QS certification in sequence of time and has a registered capital of 42 million CNY. Its main product is ‘Yang Zhenhua 851’ series products and such. ‘Yang Zhenhua 851’ owns intellectual property rights, has acquired patents in many countries including US, America, Canada, EU, Japan, Australia and so on, and its products are sold far to Western and Southeast Asian countries and regions. Staying robust for over two decades, ‘Yang Zhenhua 851’ helps ameliorate health of millions of people worldwide.
“Yang Zhenhua 851” gets its name from Yang Zhenhua, its inventor and January, 1985, the time of the invention. It was famous for its resistance against cancer, prevention of cancer and prevention of senium two decades ago; in 1993, ‘Yang Zhenhua 851’ passed the clinical test for health care drugs and obtained the reference number for national health care drugs. Its approved functions are to replenish kidney, bring health to the spleen and Qi, improve people’s immunity function and work on functions of lungs and brains. It is used as the assistance treatment for prolonging aging and chemotherapy and radiation therapy of tumor. In 1998, Professor Yang Zhenhua extracted SBA, an anti-cancer substance, from ‘Yang Zhenhua 851’ products. SBA is innocuous to normal human cells and would induce many cancer cells to demise. Many famous press including CCTV, People’s daily and so on covered it; in 2008, NCI of the US incorporated ‘Yang Zhenhua 851’ products sold in the American market (commodity name: Haelen 951 oral liquid) to the list for anti-cancer drugs. After 2009, ‘Yang Zhenhua 851’ began to sell Haelen 951 oral liquid, Q-CAN oral liquid in the American market that were approved to conduct clinical tests related with ‘cancer therapy’ and ‘muscular dystrophy’. In 2010, the clinical test on ‘Gulf War Syndrome’ in Europe by ‘Yang Zhenhua 851’ obtained good process. Many famed scientific research institutions abroad have conducted deep research on ‘Yang Zhenhua 851’ products and printed dozens of scientific research treatises internationally.
Patent certificate
The Life Spring was awarded Special Award in Basel International Invention Expo
First-grade knight medal awarded by the King of Belgium
Golden price for Brussels Eureka